So they resort to rehashing Exubra BS.
What they fail to tell you is that Exubra Patients were moved over to Afrezza.
Gee I Wonder why.
Not only that the FDA wants MNKD to test Afrezza on 4 year Old Children.
Sentiment: Strong Buy
True, so they must come up with #$%$ reports to bring down the stock.